Adcetris Approval Expanded to Include Later-Stage Hodgkin Lymphoma

TUESDAY, March 20, 2018 — U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin lymphoma, the agency said Tuesday in a news release.
The…
Source: Topamax